Search research articles
Contact Us
Filters
Showing results (141-150 of 206) with videos related to
Page
of 21
Sort By:
Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology
|
September 28, 2014
Impact of inflammatory markers on the prognosis of patients with operable breast cancer
Ibrahim Petekkaya, Sercan Aksoy, Emir C Roach, et al.
Journal of Clinical Medicine
|
August 12, 2022
The Association between Early Changes in Neutrophil-Lymphocyte Ratio and Survival in Patients Treated with Immunotherapy
Deniz Can Guven, Taha Koray Sahin, Enes Erul, et al.
Hepato-Gastroenterology
|
April 27, 2012
XELOX vs. FOLFOX4 as second line chemotherapy in advanced pancreatic cancer
Veli Berk, Nuriye Ozdemir, Metin Ozkan, et al.
Asian Pacific Journal of Cancer Prevention : APJCP
|
February 27, 2014
Predictors of outcome in patients with advanced nonseminomatous germ cell testicular tumors
Tarkan Yetisyigit, Nalan Babacan, Yuksel Urun, et al.
Irish Journal of Medical Science
|
September 2, 2021
THSD7A expression: a novel immunohistochemical determinant in predicting overall survival of metastatic renal cell carcinoma treated with targeted therapy
Oktay Halit Aktepe, Fatma Gundogdu, Kemal Kosemehmetoglu, et al.
Nature Communications
|
November 2, 2023
Toxic PARP trapping upon cAMP-induced DNA damage reinstates the efficacy of endocrine therapy and CDK4/6 inhibitors in treatment-refractory ER+ breast cancer
Ozge Saatci, Metin Cetin, Meral Uner, et al.
Cell Death and Differentiation
|
March 2, 2023
Targeting TACC3 represents a novel vulnerability in highly aggressive breast cancers with centrosome amplification
Ozge Saatci, Ozge Akbulut, Metin Cetin, et al.
Future Oncology (London, England)
|
April 13, 2019
The hematologic parameters in metastatic castration-resistant prostate cancer patients treated with abiraterone acetate
Cem Onal, Ali Murat Sedef, Fatih Kose, et al.
Immunotherapy
|
June 5, 2025
Prognostic value of serum albumin-creatinine ratio as a biomarker in patients treated with immune checkpoint inhibitors
Onur Bas, Mert Tokatlı, Naciye Guduk, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]
|
February 1, 2019
Outcome of loco-regional radiotherapy in metastatic castration-resistant prostate cancer patients treated with abiraterone acetate
Berna Akkus Yildirim, Cem Onal, Fatih Kose, et al.
Page
of 21
Search research articles
Search
Showing results (141-150 of 206) with videos related to
Sort By:
Page
of 21
Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology
|
September 28, 2014
Impact of inflammatory markers on the prognosis of patients with operable breast cancer
Ibrahim Petekkaya, Sercan Aksoy, Emir C Roach, et al.
Journal of Clinical Medicine
|
August 12, 2022
The Association between Early Changes in Neutrophil-Lymphocyte Ratio and Survival in Patients Treated with Immunotherapy
Deniz Can Guven, Taha Koray Sahin, Enes Erul, et al.
Hepato-Gastroenterology
|
April 27, 2012
XELOX vs. FOLFOX4 as second line chemotherapy in advanced pancreatic cancer
Veli Berk, Nuriye Ozdemir, Metin Ozkan, et al.
Asian Pacific Journal of Cancer Prevention : APJCP
|
February 27, 2014
Predictors of outcome in patients with advanced nonseminomatous germ cell testicular tumors
Tarkan Yetisyigit, Nalan Babacan, Yuksel Urun, et al.
Irish Journal of Medical Science
|
September 2, 2021
THSD7A expression: a novel immunohistochemical determinant in predicting overall survival of metastatic renal cell carcinoma treated with targeted therapy
Oktay Halit Aktepe, Fatma Gundogdu, Kemal Kosemehmetoglu, et al.
Nature Communications
|
November 2, 2023
Toxic PARP trapping upon cAMP-induced DNA damage reinstates the efficacy of endocrine therapy and CDK4/6 inhibitors in treatment-refractory ER+ breast cancer
Ozge Saatci, Metin Cetin, Meral Uner, et al.
Cell Death and Differentiation
|
March 2, 2023
Targeting TACC3 represents a novel vulnerability in highly aggressive breast cancers with centrosome amplification
Ozge Saatci, Ozge Akbulut, Metin Cetin, et al.
Future Oncology (London, England)
|
April 13, 2019
The hematologic parameters in metastatic castration-resistant prostate cancer patients treated with abiraterone acetate
Cem Onal, Ali Murat Sedef, Fatih Kose, et al.
Immunotherapy
|
June 5, 2025
Prognostic value of serum albumin-creatinine ratio as a biomarker in patients treated with immune checkpoint inhibitors
Onur Bas, Mert Tokatlı, Naciye Guduk, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]
|
February 1, 2019
Outcome of loco-regional radiotherapy in metastatic castration-resistant prostate cancer patients treated with abiraterone acetate
Berna Akkus Yildirim, Cem Onal, Fatih Kose, et al.
Page
of 21